Full Text View
Tabular View
No Study Results Posted
Related Studies
Exercise for Elderly Peripheral Revascularized Patients
This study has been completed.
First Received: April 24, 2008   No Changes Posted
Sponsored by: National Institute on Aging (NIA)
Information provided by: National Institute on Aging (NIA)
ClinicalTrials.gov Identifier: NCT00667290
  Purpose

The purpose of this study is (1) to determine whether a 3-month exercise rehabilitation program will improve claudication distances, free-living daily physical activity, and health-related quality of life of older, revascularized patients with peripheral arterial disease, and (2) to determine whether the primary mechanisms by which exercise rehabilitation affects the above functional outcomes are through alterations in walking efficiency, peripheral circulation, and cardiopulmonary function.


Condition Intervention
Peripheral Artery Disease
Intermittent Claudication
Behavioral: Treadmill exercise

MedlinePlus related topics: Exercise and Physical Fitness
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Parallel Assignment, Efficacy Study
Official Title: Exercise for Elderly Peripheral Revascularized Patients

Further study details as provided by National Institute on Aging (NIA):

Primary Outcome Measures:
  • Change in the walking distance to onset of leg pain, and the change in walking distance to maximal leg pain

Secondary Outcome Measures:
  • Changes in walking efficiency, calf muscle circulation, and cardiopulmonary function.

Enrollment: 80
Study Start Date: July 2000
Study Completion Date: June 2007
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental Behavioral: Treadmill exercise
Graded treadmill walking 3 times per week for 3 months
2: No Intervention

Detailed Description:

Peripheral arterial disease (PAD) patients with critical limb-threatening ischemia have improved peripheral circulation following infrainguinal revascularization. Despite this hemodynamic benefit, little change in functional status occurs, and many patients have residual ambulatory dysfunction.

The lack of functional improvement in revascularized patients may be due to extreme physical deconditioning secondary to their pre-existing critical limb-threatening ischemia. Therefore, we hypothesize that a program of aerobic exercise training is necessary to optimize ambulation, free-living daily physical activity, and health-related quality of life through the mechanisms of improved walking economy, peripheral circulation, and cardiopulmonary function.

This is a prospective, randomized controlled clinical trial comparing an exercise group undergoing a program of graded treadmill walking, and a non-exercise control group. Eighty PAD patients will be randomized into either the exercise group (N = 40) or the non-exercise control group (N = 40) following successful lower extremity arterial bypass or angioplasty. The 3-month exercise program will consist of graded treadmill walking 3 times per week with progressive increments in exercise duration from 15 to 40 minutes, and progressive increments in exercise intensity from 50 to 80% of exercise capacity.

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • lower extremity arterial bypass at least 3 months prior to screening
  • infrainguinal percutaneous transluminal angioplasty (PTLA) at least 2 weeks prior to screening

Exclusion Criteria:

  • persistent rest pain due to (peripheral artery disease (PAD) (Fontaine Stage III for PAD),
  • persistent tissue loss due to PAOD (Fontaine Stage IV for PAD),
  • medical conditions that are contraindicative for exercise according to the American College of Sports Medicine (e.g., acute myocardial infarction, unstable angina, etc.)
  • cognitive dysfunction (mini-mental state examination score of less than 24)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00667290

Locations
United States, Oklahoma
General Clinical Research Center, University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73117
Sponsors and Collaborators
Investigators
Principal Investigator: Andrew W. Gardner, PhD University of Oklahoma
  More Information

Publications:
Responsible Party: University of Oklahoma Health Sciences Center ( Andrew W. Gardner, PhD, CMRI Hobbs-Recknagel Professor )
Study ID Numbers: AG0098, R01-AG-16685
Study First Received: April 24, 2008
Last Updated: April 24, 2008
ClinicalTrials.gov Identifier: NCT00667290     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institute on Aging (NIA):
functional ability
gait
musculoskeletal disorder therapy
peripheral blood vessel disorder

Study placed in the following topic categories:
Arterial Occlusive Diseases
Signs and Symptoms
Peripheral Vascular Diseases
Musculoskeletal Diseases
Vascular Diseases
Intermittent Claudication
Arteriosclerosis

Additional relevant MeSH terms:
Arterial Occlusive Diseases
Signs and Symptoms
Vascular Diseases
Intermittent Claudication
Cardiovascular Diseases
Arteriosclerosis

ClinicalTrials.gov processed this record on May 07, 2009